EsoCap reports positive topline results from ACESO Phase II trial investigating ESO-101 in eosinophilic esophagitis
05 déc. 2023 03h00 HE
|
EsoCap AG
ESO-101, EsoCap's lead product candidate, consists of a capsule with a rolled-up, thin mucoadhesive film with the anti-inflammatory corticosteroid, mometasone furoateEsoCap's novel targeted delivery...
Sirius and Aceso Partner to Deliver the Patient Room of the Future
09 sept. 2019 10h07 HE
|
Sirius Computer Solutions, Inc.
San Antonio, TX, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Sirius Computer Solutions, Inc. (Sirius), a leading national IT solutions integrator, and Aceso® Interactive (Aceso), a premier provider of...